FI952324A - Heterosykliset karbamaatit, menetelmä niiden valmistamiseksi ja lääkkeet - Google Patents

Heterosykliset karbamaatit, menetelmä niiden valmistamiseksi ja lääkkeet Download PDF

Info

Publication number
FI952324A
FI952324A FI952324A FI952324A FI952324A FI 952324 A FI952324 A FI 952324A FI 952324 A FI952324 A FI 952324A FI 952324 A FI952324 A FI 952324A FI 952324 A FI952324 A FI 952324A
Authority
FI
Finland
Prior art keywords
carbomate
heterocyclic
drugs
preparation
heterocyclic carbomate
Prior art date
Application number
FI952324A
Other languages
English (en)
Swedish (sv)
Other versions
FI952324A0 (fi
Inventor
Thomas Pill
Peter Zeiller
Wolfram Raake
Rainer Klauser
Original Assignee
Luitpold Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luitpold Pharma Gmbh filed Critical Luitpold Pharma Gmbh
Publication of FI952324A publication Critical patent/FI952324A/fi
Publication of FI952324A0 publication Critical patent/FI952324A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI952324A 1993-10-04 1995-05-12 Heterosykliset karbamaatit, menetelmä niiden valmistamiseksi ja lääkkeet FI952324A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4333761A DE4333761A1 (de) 1993-10-04 1993-10-04 Heterocyclische Carbamate, Verfahren zu ihrer Herstellung und Arzneimittel
PCT/EP1994/003280 WO1995009842A1 (en) 1993-10-04 1994-10-04 Isoquinolinone-, phthalazinone-, quinazolinone- and benzotriazolinone derivatives, their preparation and their use as anti-thrombotics

Publications (2)

Publication Number Publication Date
FI952324A true FI952324A (fi) 1995-05-12
FI952324A0 FI952324A0 (fi) 1995-05-12

Family

ID=6499349

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952324A FI952324A0 (fi) 1993-10-04 1995-05-12 Heterosykliset karbamaatit, menetelmä niiden valmistamiseksi ja lääkkeet

Country Status (9)

Country Link
US (1) US5679677A (fi)
EP (1) EP0649839A1 (fi)
JP (1) JPH08504216A (fi)
AU (1) AU684314B2 (fi)
CA (1) CA2148361A1 (fi)
DE (2) DE4333761A1 (fi)
FI (1) FI952324A0 (fi)
NO (1) NO952205L (fi)
WO (1) WO1995009842A1 (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7261742B2 (en) * 2005-10-13 2007-08-28 S.C. Johnson & Son, Inc. Method of deodorizing a textile
US7407922B2 (en) * 2005-10-13 2008-08-05 S.C. Johnson & Son, Inc. Deodorizing compositions
KR101419075B1 (ko) * 2006-08-08 2014-07-11 아스카 세이야쿠 가부시키가이샤 퀴나졸린 유도체
US9604931B2 (en) 2007-01-22 2017-03-28 Gtx, Inc. Nuclear receptor binding agents
CN101641013B (zh) 2007-01-22 2014-07-30 Gtx公司 核受体结合剂
US9623021B2 (en) 2007-01-22 2017-04-18 Gtx, Inc. Nuclear receptor binding agents
ES2576643T3 (es) 2007-03-09 2016-07-08 Second Genome, Inc. Compuestos de bicicloheteroarilo como moduladores de P2X7 y usos de los mismos
JP5848761B2 (ja) * 2010-06-24 2016-01-27 アルカーメス ファーマ アイルランド リミテッド Nh酸性化合物のプロドラッグ:エステル、カルボネート、カルバメートおよびホスホネートの誘導体
WO2012058211A2 (en) * 2010-10-29 2012-05-03 Emory University Quinazoline derivatives, compositions, and uses related thereto
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
JP6466924B2 (ja) 2013-10-04 2019-02-06 インフィニティー ファーマシューティカルズ, インコーポレイテッド 複素環式化合物及びその使用
WO2015051241A1 (en) 2013-10-04 2015-04-09 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US9775844B2 (en) 2014-03-19 2017-10-03 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US9708348B2 (en) 2014-10-03 2017-07-18 Infinity Pharmaceuticals, Inc. Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
CA2998469A1 (en) 2015-09-14 2017-03-23 Infinity Pharmaceuticals, Inc. Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same
WO2017161116A1 (en) 2016-03-17 2017-09-21 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
US10919914B2 (en) 2016-06-08 2021-02-16 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE36226B1 (en) * 1935-11-11 1976-09-15 Shimamoto Takio Phthalazone derivatives
FR1460552A (fr) * 1965-04-22 1966-03-04 Agripat Sa Additifs à des nourritures pour animaux
NL6702189A (fi) * 1967-02-14 1968-08-15
DE1807685A1 (de) * 1968-11-08 1970-08-06 Chinoin Gyogyszer Es Vegyeszet Neue Chinazolon-Derivate und Verfahren zur Herstellung derselben
CH540266A (de) * 1968-12-04 1973-08-15 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von Chinazolon-Derivaten
JPS5418270B2 (fi) * 1971-12-06 1979-07-06
AR205004A1 (es) * 1973-10-30 1976-03-31 Ishikawa M Procedimiento para preparar derivados de 6,8-dialquil-7-alcoxi-carbonil-4-hidroximetil-1-ftalazona y la 7,8-lactona
US4293553A (en) * 1978-08-11 1981-10-06 Masayuki Ishikawa 1-Phthalazone derivatives, and use thereof
GB2127805A (en) * 1982-09-13 1984-04-18 Showa Denko Kk Phthalazones
JPS5976069A (ja) * 1982-10-25 1984-04-28 Showa Denko Kk フタラゾン誘導体
US4769367A (en) * 1984-04-24 1988-09-06 Glaxo Group Limited Heterocyclic amino compounds

Also Published As

Publication number Publication date
AU684314B2 (en) 1997-12-11
CA2148361A1 (en) 1995-04-13
DE4345266A1 (de) 1995-06-29
US5679677A (en) 1997-10-21
DE4345266C2 (de) 1996-12-19
NO952205D0 (no) 1995-06-02
AU7784594A (en) 1995-05-01
FI952324A0 (fi) 1995-05-12
DE4333761A1 (de) 1995-04-06
WO1995009842A1 (en) 1995-04-13
JPH08504216A (ja) 1996-05-07
EP0649839A1 (en) 1995-04-26
NO952205L (no) 1995-06-02

Similar Documents

Publication Publication Date Title
FI941137A0 (fi) 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
FI953981A (fi) 2-Bentsyyli-polysykliset guaniinijohdannaiset ja menetelmä niiden valmistamiseksi
FI893542A0 (fi) Entsyymielektrodit ja menetelmä niiden valmistamiseksi
FI953479A (fi) 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
FI952324A (fi) Heterosykliset karbamaatit, menetelmä niiden valmistamiseksi ja lääkkeet
IS3720A7 (is) Afleiður dialkoxy-pyridinyl-benzimidazole, aðferðvið lögun þeirra og lyfjafræðileg notkun
FI953898A0 (fi) Glysiiniamidijohdannaisia, menetelmiä niiden valmistamiseksi ja niitä sisältäviä lääkeaineita
BR9101250A (pt) Metodo e aparelhagem de medicao de distancia
FI962344A0 (fi) Järjestelmä ja menetelmä selluloosan sisäänruiskuttamiseksi
FI941777A0 (fi) Vesipitoinen farmaseuttinen suspensio ja menetelmä sen valmistamiseksi
FI935485A0 (fi) PEG-hydrazon- och PEG-oximbindningen bildande reagens och proteinderivat daerav
FI954718A0 (fi) Heterosykliset johdannaiset iskeemian ja vastaavien sairauksien hoitamiseksi
FI962445A (fi) Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi
FI95914C (fi) Polypeptidijohdannaisia ja menetelmä niiden valmistamiseksi
FI944906A (fi) Uudet sykliset aminohapot ja niiden johdannaiset
FI964310A0 (fi) Imidatsolijohdannainen ja menetelmä sen valmistamiseksi
FI941914A0 (fi) 2-amino-4-kinoliinidihydropyridiinejä, menetelmiä niiden valmistamiseksi ja niiden käyttö
FI944842A0 (fi) Fluoratut 4-aminoandrostadienonijohdannaiset ja menetelmä niiden valmistamiseksi
FI961977A0 (fi) N-substituoidut atsabisykloalkaanijohdannaiset, niiden valmistus ja käyttö
FI940403A0 (fi) Elliptisiinijohdannainen ja menetelmä sen valmistamiseksi
ATE202351T1 (de) Pyridinderivate und sie enthaltende pharmazeutische zubereitungen
FI964148A (fi) Julkisivumateriaali ja menetelmä sen valmistamiseksi
BR9106582A (pt) Derivados de tetrazol e medicamentos
NZ239186A (en) Substituted 2-(9-fluorenonyl)-carbapenem derivatives and pharmaceutical
FI930378A (fi) Fosfenoxidavslutade allen-en-yn dna-spjaelkande, antitumoer och antibiotika molekyler